Article Text
Commentary
Targeting metalloproteases is a promising strategy to enhance immunotherapy responses by overcoming immune exclusion in hepatocellular carcinoma
Statistics from Altmetric.com
Footnotes
Contributors Both authors contributed to the design and writing of the commentary.
Funding MB-V was supported by Cholangiocarcinoma Foundation (CCF) Research Fellowship, and by the Postdoctoral Fellowship Grant from Ramon Areces Foundation. PB was supported by Instituto de Salud Carlos III (PI22/00147) co-financed by Fondos Feder, Gobierno de Navarra Proyecto ARNMUNE Ref: 0011–1411-2023, and a 2022 Leonardo Grant for Researchers and Cultural Creators, BBVA Foundation.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer-reviewed.